Autolus Therapeutics Ltd | AUTL - Operating Expenses

Stock Price
1.50
Daily Change
0.06 4.17%
Monthly
-0.66%
Yearly
-17.58%
Q1 Forecast
1.41

Autolus Therapeutics Ltd reported $92.82M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
AstraZeneca USD 12.53B 4.16B Dec/2025
Autolus Therapeutics Ltd USD 92.82M 10.21M Sep/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Novartis USD 9.86B 115M Sep/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Silence Therapeutics USD 23.68M 4.76M Sep/2024